MFS
VNRX icon

Miller Financial Services’s VolitionRx Ltd VNRX Stock Holding History

Miller Financial Services’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,550
Closed -$6.26K – 151
2026
Q1 		$6.26K Buy
+1,550
New +$7.4K 0.01% 120

Other funds holding VNRX

LIM
Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Miller Financial Services's VNRX Position: Q2 2026 in Review

Miller Financial Services sold out of VolitionRx Ltd (VNRX) in Q2 2026, closing a stake of 1,550 shares — an estimated $6.26K sold.

Miller Financial Services first reported a position in VNRX in Q1 2026 and held it in 1 quarter. The position peaked at $6.26K in Q1 2026. 25 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Miller Financial Services reported no remaining VolitionRx Ltd position as of Q2 2026 after selling out during the quarter.
  • Miller Financial Services sold 1,550 VolitionRx Ltd shares in Q2 2026, an estimated $6.26K.
  • Miller Financial Services first reported a position in VolitionRx Ltd in Q1 2026 and held it in 1 quarter.
  • Miller Financial Services's VolitionRx Ltd position peaked at $6.26K in Q1 2026.
  • 25 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Miller Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.